DocGo Inc. Earnings Per Share (Diluted)
DocGo Inc. (DCGO) reported Earnings Per Share (Diluted) of -$0.16 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-17.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareDiluted · last filed 2026-08-17
- DocGo Inc. earnings per share, diluted for the quarter ending 2026-06-30 was -$0.16.
- DocGo Inc. earnings per share, diluted for the quarter ending 2026-03-31 was -$0.15.
- DocGo Inc. earnings per share, diluted for the quarter ending 2025-09-30 was -$0.28, a 660.00% decline year-over-year.
- DocGo Inc. earnings per share, diluted for the quarter ending 2025-06-30 was -$0.11, a 283.33% decline year-over-year.
- DocGo Inc. earnings per share, diluted for fiscal 2025 was -$1.84, a 1122.22% decline from fiscal 2024.
- DocGo Inc. earnings per share, diluted for fiscal 2024 was $0.18, a 200.00% increase from fiscal 2023.
- DocGo Inc. earnings per share, diluted for fiscal 2023 was $0.06, a 82.35% decline from fiscal 2022.
- DocGo Inc. earnings per share, diluted for fiscal 2022 was $0.34, a 36.00% increase from fiscal 2021.
| Period end | Earnings Per Share, Diluted 3 month | Earnings Per Share, Diluted 6 month | Earnings Per Share, Diluted 9 month | Earnings Per Share, Diluted 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$0.16 10-Q · filed 2026-08-17 | -$0.31 10-Q · filed 2026-08-17 | ||
| 2026-03-31 | -$0.15 10-Q · filed 2026-05-11 | |||
| 2025-12-31 | -$1.84 10-K · filed 2026-03-16 | |||
| 2025-09-30 | -$0.28 10-Q · filed 2025-11-10 | -$0.49 10-Q · filed 2025-11-10 | ||
| 2025-06-30 | -$0.11 10-Q · filed 2026-08-17 | -$0.21 10-Q · filed 2026-08-17 | ||
| 2025-03-31 | -$0.09 10-Q · filed 2026-05-11 | |||
| 2024-12-31 | $0.18 10-K · filed 2026-03-16 | |||
| 2024-09-30 | $0.05 10-Q · filed 2025-11-10 | $0.22 10-Q · filed 2025-11-10 | ||
| 2024-06-30 | $0.06 10-Q · filed 2025-08-07 | $0.17 10-Q · filed 2025-08-07 | ||
| 2024-03-31 | $0.10 10-Q · filed 2025-05-08 | |||
| 2023-12-31 | $0.06 10-K · filed 2026-03-16 | |||
| 2023-09-30 | $0.05 10-Q · filed 2024-11-07 | -$0.01 10-Q · filed 2024-11-07 | ||
| 2023-06-30 | -$0.02 10-Q · filed 2024-08-07 | -$0.05 10-Q · filed 2024-08-07 | ||
| 2023-03-31 | -$0.03 10-Q · filed 2024-05-08 | |||
| 2022-12-31 | $0.34 10-K · filed 2025-02-27 | |||
| 2022-09-30 | $0.03 10-Q · filed 2023-11-06 | $0.14 derived: net income ÷ weighted average shares · filed 2023-11-06 | $0.24 10-Q · filed 2023-11-06 | |
| 2022-06-30 | $0.11 10-Q · filed 2023-08-08 | $0.20 10-Q · filed 2023-08-08 | ||
| 2022-03-31 | $0.09 10-Q · filed 2023-05-09 | |||
| 2021-12-31 | $0.25 10-K · filed 2024-02-28 | |||
| 2021-09-30 | $0.04 10-Q · filed 2022-11-08 | $0.00 10-Q · filed 2022-11-08 | ||
| 2021-06-30 | -$18.19 10-Q · filed 2022-08-09 | -$36.73 10-Q · filed 2022-08-09 | ||
| 2021-03-31 | -$0.03 10-Q · filed 2022-05-10 | |||
| 2020-12-31 | -$0.25 10-K · filed 2022-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B | ||
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |